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Abstract 
Mississippi is currently experiencing an HIV/AIDS crisis. The state is ranked in the top 
10 for diagnoses of HIV infection, with Jackson, Mississippi ranked sixth in the nation for HIV 
diagnoses and fourth in the nation for AIDS diagnoses. Despite antiretroviral treatment allowing 
for persons with HIV to lead healthy lives, Mississippians continue to die from AIDS in large 
part because of stigma, misinformation, and lack of resources. This is furthered by Mississippi’s 
HIV criminalization law. HIV criminalization laws are used to penalize HIV exposure, but HIV-
specific criminal laws are considered largely ineffective public health policies because these 
statutes further stigmatize, do not account for lack of criminal intent, include misinformation, 
and do not reduce infection rates. Mississippi Code ANN. § 97-27-14 perpetuates all of these 
issues by including saliva, urine, and feces as a crime of endangerment by bodily substance, even 
though these substances have very low risk of transmitting HIV. In this study, Mississippi’s 
existing policy was identified using the Center for Disease Control and Prevention’s Policy 
Analytical Framework, and three possible policy options were analyzed and scored based on 
public health impact, feasibility, and economic and budgetary impact. Results of this analysis 
strongly indicate that Mississippi Code ANN. § 97-27-14 should be amended to be scientifically 
accurate and include a criminalization clause based on the National HIV/AIDS Strategy for the 
United States goals and the United States Department of Justice Civil Rights Division best 
practices. 
 
Key words: HIV/AIDS, HIV-specific criminalization laws, HIV criminalization, Mississippi, 
crime of endangerment by bodily substance, Mississippi Code ANN. § 97-27-14  
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Chapter 1: Introduction 
 In the United States of America, new incidences of HIV have significantly decreased in 
large part because of prevention efforts and drugs such as antiretroviral therapy, pre-exposure 
prophylaxis, and post-exposure prophylaxis that greatly reduce possible transmission. Despite 
tremendous progress, these trends are not seen in the Deep South where HIV rates continue to 
rise. From 2006 to 2015, newly diagnosed cases of HIV in Mississippi rose by 10% (Mississippi 
State Department of Health, STD/HIV Office, 2016).  In Mississippi, almost 80% of diagnoses 
and mortality rates are African Americans showcasing a large health disparity (Mississippi State 
Department of Health, STD/HIV Office, 2016).  To further this issue, Mississippi has the second 
highest percentage for prisoners living with HIV (Maruschak & Bronson, 2017).  Mississippi is 
experiencing a HIV/AIDS crisis, and this crisis is further exacerbated by Mississippi HIV 
criminalization law. 
 HIV-specific criminalization laws are criminal statues used to prosecute and punish those 
living with HIV. These laws were created to inhibit the spread of HIV and protect others from 
being exposed to HIV, yet HIV criminalization is considered ineffective public health policy. 
These statues are stigmatizing, do not account for lack of criminal intent or transmission, include 
misinformation, and do not reduce infection rates. Mississippi HIV criminalization law, 
Mississippi Code Ann. § 97-27-14, embodies these implications as the statute includes 
scientifically incorrect information, a stigmatizing discrepancy between a misdemeanor and 
felony only based on knowing one’s HIV status, and is HIV-specific. The Center for Disease 
Control and Prevention and the United States Department of Justice recommends that states 
reform HIV-specific criminal laws by repealing the statues, but, if this is not feasible, to amend 
the policies to be scientifically correct and include a criminal intent clause.  
  2 
 The purpose of this study was to prioritize the most appropriate policy option to reform 
Mississippi HIV criminalization law. Using Center for Disease Control and Prevention’s Policy 
Analytical Framework, policy options were developed, analyzed, and prioritized based on public 
health impact, feasibility, and economic and budgetary impact. Results were analyzed, and a 
strategy was created to reform Mississippi HIV criminalization to be more equitable.  
 
  
  
  3 
Chapter 2: Literature Review 
HIV/AIDS Basics 
HIV stands for human immunodeficiency virus, and if the virus if left untreated leads to 
AIDS, which is acquired immunodeficiency syndrome. HIV attacks the body’s immune system 
by targeting CD4 T lymphocytes , commonly known as CD4 cells or T cells (HIV.gov, 2017). 
CD4 T lymphocytes “help coordinate the immune response by stimulating other immune cells… 
to fight off infection;” through the destruction of these white blood cells, HIV weakens the 
immune system leaving the individual more susceptible to infections (AIDSinfo, n.d.). HIV is 
spread from a person who has HIV through certain bodily fluids including “blood, semen (cum), 
pre-seminal fluid (pre-cum), rectal fluids, vaginal fluids, and breast milk” (Center for Disease 
Control and Prevention, 2018b).  This transmission is done via certain behaviors with the most 
common modes of transmission in the United States being unprotected sex and re-use of needles 
from intravenous drugs, yet transmission can occur if the virus comes in contact with a mucous 
membrane, damaged tissue, or bloodstream (Center for Disease Control and Prevention, 2018b). 
There is currently no cure for HIV/AIDS, but antiretroviral treatments allow for the prevention 
and management of HIV/AIDS. If left untreated, HIV progresses to three stages: the acute HIV 
infection stage, the chronic HIV infection stage, and then finally AIDS (HIV.gov, 2017). 
 Acute HIV infection occurs 2-4 weeks after HIV infection and is the first stage of HIV.  
This stage is often characterized by flu-like symptoms including headaches, rashes, and fever 
(AIDSinfo, 2018). Despite this characterization, many people do not experience these symptoms 
and “are often unaware that they’re infected because they may not feel sick right away or at all” 
(Center for Disease Control and Prevention, 2019a).  During the acute HIV infection stage, the 
virus is extensively produced causing CD4 T lymphocytes counts to fall rapidly. Because of the 
high levels of virus production, individuals “are at very high risk of transmitting HIV to… sexual 
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or needle-sharing partners” (HIV.gov, 2017). Eventually, the immune system responds to the 
HIV infection, and the “rapid replication of HIV declines and the person's viral load drops to its 
set point” meaning that the HIV viral load stabilizes (AIDSinfo, 2019).  Once the viral load 
reaches the set point, CD4 T lymphocytes counts begin to rise, but the levels “may not return to 
pre-infection levels” (HIV.gov, 2017). 
 The acute HIV stage eventually progresses to the chronic HIV infection stage commonly 
called “clinical latency.” This second stage is characterized by individuals experiencing little or 
no HIV related symptoms. The virus reproduces at extremely low levels and “cannot be detected 
with standard laboratory tests” (HIV.gov, 2017). Despite the low viral load, HIV can still be 
spread to others during the chronic infection stage (Center for Disease Control and Prevention, 
2019a). Without any treatment, this stage can last approximately 10 years and eventually 
advances to AIDS (AIDSinfo, 2018). 
 AIDS is the final stage of HIV infection. This is the most severe stage of HIV and is 
characterized by opportunistic infections, very low numbers of CD4 T lymphocytes, and 
common symptoms including: “chills, fever, sweats, swollen lymph glands, weakness, and 
weight loss” (Center for Disease Control and Prevention, 2019a). For diagnosis, one is 
considered to have progressed to AIDS if CD4 T lymphocytes fall below 200 cells per cubic 
millimeter of blood or if the individual develops an opportunistic illness (AIDSinfo, 2018). 
Concerning cell counts, a normal number of CD4 T lymphocytes ranges from 500 to 1,500 
meaning that persons living with AIDS have less than 50% to less than 10% of the normal cell 
count (U.S. Department of Veterans Affairs, 2018). Concerning opportunistic infections, these 
are infections that take advantage of a weakened immune system and include diseases such as 
cryptococcal meningitis, toxoplasmosis, esophageal candidiasis, and other infections (Avert, 
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2018). Without treatment, those with AIDS live for approximately 3 years, but this is often 
shortened if exposed to an opportunistic illness (AIDSinfo, 2018). 
 If an individual contracts HIV, the virus can be managed through antiretroviral therapy, 
commonly known as ART. ART consist of various medications that treat HIV by preventing the 
growth of the virus. Antiretroviral drugs, commonly referred to as ARV, are not cures for 
HIV/AIDS, but when used in combination (combination therapy) allow for reduced viral load 
(The AIDS InfoNet, 2014). When using ART, the person living with HIV’s viral load can be 
undetectable meaning that if they were to test for HIV, they would test negative and would not 
be able to transmit the virus. These drugs should begin to be taken once tested positive for HIV 
and allows for persons living with HIV/AIDS to live long, healthy lives.  
HIV/AIDS can be prevented through certain behaviors and drugs. The only methods that 
absolutely prevent the spread of HIV/AIDS are abstinence and not sharing needles from 
intravenous drugs, but there are numerous other very effective methods. Other prevention 
methods include limiting number of sexual partners, using condoms correctly every time the 
individual has sex, and taking “advantage of newer HIV prevention medicines such as pre-
exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP)” (Center for Disease Control 
and Prevention, 2019c)  
  PrEP and PEP are antiretroviral drugs used to reduce one’s susceptibility of contracting 
HIV. PEP is a HIV prevention drug used in emergency situations where the individual could 
have been potentially exposed to HIV (Center for Disease Control and Prevention, 2018d). PEP 
is a pill taken “once or twice daily for 28 days” and must be administered within 72 hours after 
being possibly exposed (HIV.gov, 2018). PrEP is “a new HIV prevention approach where HIV-
negative individuals use anti-HIV medications to reduce their risk of becoming infected if they 
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are exposed to the virus” (San Francisco AIDS Foundation, 2018). Essentially, this is a pill taken 
by those who do not have HIV and it greatly reduces chances of contracting HIV by blocking the 
virus from reproducing. Studies have shown that when taken daily, “PrEP reduces the risk of 
getting HIV from sex by more than 90%” and “reduces the risk of getting HIV by more than 
70%” (Center for Disease Control and Prevention, 2019b). These drugs greatly reduce one’s risk 
of contracting HIV if properly taken. 
HIV/AIDS in the United States 
Currently, there are approximately 1.1 million people living in the United States with 
HIV and half of these people are virally suppressed (HIV.gov, 2019). Nationally, annual rates of 
HIV infections and diagnoses are declining, which is attributed to HIV prevention initiatives 
such as education, resources, and drugs (Center for Disease Control and Prevention, 2018a).  
Despite the nationally decreasing trend, the Deep South region of the United States 
consisting of Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, 
and Texas “has been disproportionately affected by HIV, as this region has consistently 
experienced the highest HIV diagnosis rates and death rates of any US region” (Reif et al., 
2017). This alarming HIV/AIDS trend in the Deep South continues as almost 50% of those living 
with HIV/AIDS are in the Southern United States despite this area making up less than 40% of 
the nation’s population (McAllaster, 2014). Minority populations are especially impacted by 
HIV/AIDS diagnoses and deaths as African Americans represent the majority of new incidences 
and prevalence of HIV/AIDS in the Deep South. This is especially prevalent in “new diagnoses 
among African American men who have sex with men” (Reif et al., 2017). 
Another important population that is disproportionately impacted by HIV/AIDS in the 
United States are those incarcerated. According to the Bureau of Justice Statistics, there are 
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approximately 2,162, 400 incarcerated people in the United States (Kaeble & Cowhig, 2018). 
This mass incarceration in the United States has a “high concentration of HIV infection within 
correctional facilities;” this in part of because of imprisonment of those for “illicit drug use” and 
drug laws leading “to substantial increase in incarceration rates for African American men,” 
which are both populations that have higher rates of HIV (Whol, 2016). In 2015, there were 
approximately 17,000 prisoners with HIV (Maruschak & Bronson, 2017). This translates to 
approximately 1.3% of “prisoners who had HIV as a percent of custody population” (Maruschak 
& Bronson, 2017). To further elaborate, “an estimated 14% of all persons living with HIV 
infection in the United States, and 20% of African American HIV-Infected individuals, pass 
through a jail or prison each year” further showing the HIV prevalence in prisons (Wohl, 2016). 
HIV disproportionately impacts African American males in the prison system even with the fact 
that national HIV trends in the incarcerated are falling (Maruschak & Bronson, 2017).  
HIV/AIDS in Mississippi  
Mississippi follows trends seen in the Deep South. From 2006 to 2015, “there was a 10% 
increase in the number of newly reported HIV diagnoses in the state of Mississippi” juxtaposing 
national decreases (Mississippi State Department of Health, STD/HIV Office, 2016). In 2015, 
there were approximately 10,000 people living with HIV/AIDS, and of this population, almost 
80% were African American; this translates to “the rate of Black males living with an HIV 
diagnosis is 5.4 times that of White males” and “the rate of Black females living with an HIV 
diagnosis is 9.6 times that of White females” (AIDSVu, 2018). This health disparity that African 
Americans make up approximately 40% of Mississippi’s population yet make up 80% of 
incidences, prevalence, and deaths among those living with HIV (Mississippi State Department 
of Health, STD/HIV Office, 2016). Mississippi also followed regional trends in that the primary 
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transmission rate of HIV was through men having sex with men (AIDSVu, 2018). In relation to 
other states in the nation, Mississippi is the ninth in the nation for new diagnoses of HIV rate and 
sixth in the nation for the rate of AIDS diagnoses; Jackson, Mississippi ranked sixth highest for 
diagnoses of HIV and fourth highest for AIDS diagnoses (Center for Disease Control and 
Prevention, 2018a). These numbers showcase that despite effective treatment, HIV transmission 
and death by AIDS continue to remain prevalent in Mississippi. 
 HIV/AIDS in Mississippi’s prison population also show alarming trends. There are 
approximately 29,000 people incarcerated in Mississippi; Hispanics make up the majority of the 
population followed by African Americans, Native Americans, and lastly Caucasians (Prison 
Policy Initiative, n.d.). There are approximately 2.1% of “prisoners who had HIV as a percent of 
custody population,” which is the second highest percentage in the nation (Maruschak & 
Bronson, 2017). Mississippi’s alarming rates of HIV/AIDS are also prevalent in the prison 
system.  
HIV Criminalization Nationally 
 HIV criminalization is defined as “use of criminal law to penalize alleged, perceived, or 
potential HIV exposure; alleged nondisclosure of a known HIV-positive status prior to sexual 
contact (including acts that do not risk HIV transmission); or non-intentional HIV transmission” 
(The Elizabeth Taylor AIDS Foundation, 2018). This is the “application of criminal law to 
people living with HIV based solely on their HIV status,” and many of these statutes “allow 
prosecution for acts that constitute no or very little risk by failing to recognize condom use or 
low viral load or by criminalizing spitting, biting, scratching or oral sex” (Bernard & Cameron, 
2016). HIV criminalization laws were first enacted in 1986 (Lehman et al., 2014). Prosecution of 
these laws first emerged in the United States in 1987, five years after the United States 
  9 
recognized AIDS as a medical disorder and one year after the virus became known as HIV; this 
was a time of widespread panic exacerbated by “inaccurate and contradictory public health 
statements and media reports regarding transmission of the agent” (Bernard, 2010). Justifications 
of these laws are public health measures “to inhibit the spread of HIV” and “protect persons from 
exposure to infection with HIV” (Cameron, 2009).  
 From a 2014 review cosponsored by the Centers for Disease Control and Prevention and 
the U.S. Department of Justice, in the United States there are currently “33 states that have one 
or more HIV-specific criminal laws” making up 67 laws (Lehman et al., 2014). Of these states, 
“24 require persons who are aware that they have HIV to disclose their status to sexual partners,” 
14 states “require disclosure to needle-sharing partners,” 13 states “criminalize 
prostitution/solicitation,” 11 states “criminalize behaviors such as biting, spitting, and throwing 
bodily fluids, most often in the context of prisons and correctional facilities,” 19 states 
“criminalize donating blood,” and “HIV-specific criminal laws are classified as felonies in 28 
states” (Lehman et al., 2014). Most of these laws “were passed before studies showed that 
antiretroviral therapy (ART) reduces HIV transmission risk and most laws do not account for 
HIV prevention measures that reduce transmission risk, such as condom use, ART, or pre-
exposure prophylaxis” (Lehman et al., 2014).  
Using HIV criminalization law, there have been at least 104 convictions and/or 
prosecutions between 2013 and 2015 (Bernard & Cameron, 2016). Since being enacted in 1987, 
“a reported national total of at least 350 prosecutions” have occurred (UNAIDS, 2012). This data 
is difficult to assess on a national level “because state-level prosecution and arrest data are not 
readily available in any national legal database,” so “the number of prosecutions, arrests, and 
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instances where HIV-specific criminal laws are used to induce plea agreements is unknown” 
(Lehman et al., 2014).  
HIV Criminalization in Mississippi 
 Mississippi Code also reflects HIV criminalization. Mississippi Code ANN. § 97-27-14 
criminalizes “causing exposure to human immunodeficiency virus (HIV)” and the “crime of 
endangerment by bodily substance.” Mississippi Code ANN. § 97-27-14 states: 
“(1) It shall be unlawful for any person to knowingly expose another person to human 
immunodeficiency virus (HIV), hepatitis B or hepatitis C. Prior knowledge and willing 
consent to the exposure is a defense to a charge brought under this paragraph. A violation 
of this subsection shall be a felony. 
(2)  
(a) A person commits the crime of endangerment by bodily substance if the person 
attempts to cause or knowingly causes a corrections employee, a visitor to a correctional 
facility or another prisoner or offender to come into contact with blood, seminal fluid, 
urine, feces or saliva. 
(b) As used in this subsection, the following definitions shall apply unless the context 
clearly requires otherwise: 
(i) “Corrections employee” means a person who is an employee or contracted employee 
of a subcontractor of a department or agency responsible for operating a jail, prison, 
correctional facility or a person who is assigned to work in a jail, prison or correctional 
facility. 
(ii) “Offender” means a person who is in the custody of the Department of Corrections. 
(iii) “Prisoner” means a person confined in a county or city jail. 
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(c) A violation of this subsection is a misdemeanor unless the person violating this 
section knows that he is infected with human immunodeficiency virus (HIV), hepatitis B 
or hepatitis C, in which case it is a felony. 
(3) Any person convicted of a felony violation of this section shall be imprisoned for not 
less than three (3) years nor more than ten (10) years and a fine of not more than Ten 
Thousand Dollars ($10,000.00), or both. 
(4) Any person guilty of a misdemeanor violation of this section shall be punished by 
imprisonment in the county jail for up to one (1) year and may be fined One Thousand 
Dollars ($1,000.00), or both. 
(5) The provisions of this section shall be in addition to any other provisions of law for 
which the actions described in this section may be prosecuted.” 
This law was enacted in 2004, almost 20 years after first HIV laws emerged. Only three 
states have enacted HIV criminalization laws after Mississippi (Lehman et al., 2014). Since 
2004, there have been two prosecutions and two convictions under this code (Sero, n.d.).  
Implications of HIV Criminalization 
 HIV criminalization is considered ineffective public health public health policy as 
advocated by countless HIV/AIDS organizations and research. The four primary arguments 
against HIV criminalization are that these statues further stigma, unnecessarily criminalize those 
who do not have criminal intent, do not reflect current scientific information, and are ineffective 
at reducing prevalence.  
  Stigma plays a central role in HIV criminalization. “Overall, two-thirds (22 of 33) of 
states enacted their first [HIV criminalization] law” before 1990 meaning that most states that 
have HIV criminalization statutes passed in the midst of the AIDS epidemic, a time in American 
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history filled with fear, confusion, and misinformation surrounding the disease (Lehman et al., 
2014). HIV/AIDS has been stigmatized for two primary reasons: “the fact that HIV is sexually 
transmitted and the fact that it is predominantly found in groups that are already socially 
disfavored or marginalized: gay men, the poor, black Africans, women, those who use drugs, sex 
workers;” the stigma often contributed to the enactment of these laws (Cameron, 2009). In the 
publication by the HIV Justice Network and the Global Network of People Living with HIV 
(GNP+) entitled Advancing HIV Justice 2, Edwin Cameron, Constitutional Court of South Africa 
and HIV activist, states: 
“The enactment and enforcement of HIV-specific criminal laws – or even the threat of 
their enforcement – fuels the fires of stigma. It reinforces the idea that HIV is shameful, 
that it is a disgraceful contamination. And by reinforcing stigma, HIV criminalization 
makes it more difficult for those at risk of HIV to access testing and prevention. It also 
makes it more difficult for those living with the virus to talk openly about it, and to be 
tested, treated and supported” (Bernard & Cameron, 2016). 
 In the criminalization of HIV/AIDS, shame and fear are reinforced, which can discourage 
individuals from accessing needed testing and resources. Ultimately, these laws are enacted 
because of stigma associated with HIV/AIDS, and these laws further foster stigma associated 
with HIV/AIDS. 
 Another reason that HIV criminalization is considered poor public health methodology is 
that these laws punish those without criminal intent. HIV-specific criminal law “fails to uphold 
the legal and judicial fairness (including key criminal law principles of legality, foreseeability, 
intent, causality, proportionality, and proof)” (Bernard & Cameron, 2016). HIV criminality 
allows for prosecution of those who did not transmit the disease and had no criminal intent. 
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Edwin Cameron states “defendants have been punished less for what they did than for the virus 
they carried” meaning that the crime is more associated with HIV than the specified act 
(Cameron, 2009).  
 HIV-specific criminalization laws are also ineffective because the statues often do not 
reflect current scientific information. These policies are filled with “persistent misinformation 
about routes of HIV transmission,” which showcase that the policies are based on ignorance 
and/or stigma (Kelly, 2012). Saliva, urine, feces, and biting are commonly included in HIV-
specific criminalization laws, yet these bodily fluids and actions pose negligible risk for viral 
transmission. Scientifically incorrect information misleads individuals in how HIV is transmitted 
and criminalizes those living with HIV for exposing others to HIV even though their actions and 
bodily fluids cannot transmit HIV. Ultimately. HIV-specific criminalization laws that include 
incorrect scientific information spread misinformation encouraging stigma and criminalize those 
living with HIV for no harm committed.  
 Despite being enacted to inhibit the spread of HIV and protect others from getting HIV, 
HIV-specific criminalization laws do not work. There is a “general lack of evidence that HIV-
specific criminal laws have reduced transmission” (Lehman et.al., 2014). Numerous studies have 
shown limited impact of HIV-specific criminal laws on reducing HIV rates, even though the 
primary reason these laws exist are to reduce transmission rates. 
 Ultimately, HIV-specific criminal laws undermine HIV prevention, treatment, and care 
efforts. Studies have exhibited that “there is no good public health reason to treat sexual behavior 
involving HIV exposure as a crime, and… it is very difficult or impossible to do so fairly” 
(Burris, Beletsky, Burleson, Case, and Lazzarini, 2007). These laws are HIV-specific meaning 
that “the laws only apply to people who know their status” causing the statues to have the 
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potential to be “powerful disincentives for voluntary testing” (Burris et. al., 2007). These HIV-
specific statues further stigma while singling out those living with HIV, which can discourage 
testing, further transmission of the virus by those who do not test, and discourage those living 
with HIV to access needed resources. HIV-specific criminal statues hinder prevention, treatment, 
and care efforts, whose efforts significantly reduce the spread of HIV and decrease the chances 
of HIV progressing to AIDS.  
Best Practices 
 In a study published by both the Center for Disease Control and Prevention and the 
United States Department of Justice, HIV-specific criminal state laws were analyzed to conclude 
that states should “assess the laws’ alignment with current evidence regarding transmission risk, 
and consider whether the laws are the best vehicle to achieve their intended purposes” (Lehman 
et.al., 2014). This suggestion was furthered by the United States Department of Justice Civil 
Rights Division’s publication entitled Best Practices Guide to Reform HIV-Specific Criminal 
Laws to Align with Scientifically-Supported Factors (2014). The publication states: 
“Generally, the best practice would be for states to reform these laws to eliminate HIV- 
specific criminal penalties except in two distinct circumstances. First, states may wish to 
retain criminal liability when a person who knows he/she is HIV positive commits a 
(non-HIV specific) sex crime where there is a risk of transmission (e.g., rape or other 
sexual assault). The second circumstance is where the individual knows he/she is HIV 
positive and the evidence clearly demonstrates that individual’s intent was to transmit the 
virus and that the behavior engaged in had a significant risk of transmission, whether or 
not transmission actually occurred.” (U.S. Department of Justice Civil Right Division, 
2014).  
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These findings are further validated by the National HIV/AIDS Strategy for the United 
States: Updated to 2020. This strategy includes the United States Department of Justice Civil 
Rights Division best practices to reform HIV-specific criminal laws in their list of achievements 
and include in their recommended actions for state governments to ensure their “criminal laws 
reflect current scientific information regarding HIV transmission and prevention” and that “anti-
stigma civil rights messages” are in Federal documents (The White House Washington, 2015).  
These studies and governmental publications show that the ideal public health solution 
for HIV-specific criminal laws is to repeal these statues to alleviate stigma related to these 
policies. If repeal is not possible, then these statutes should be reexamined and amended to be 
scientifically accurate, include a clause for criminal intent, and reduce stigma. 
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Chapter 3: Statement of Problem 
Amidst national decreasing trends, Mississippi’s HIV/AIDS prevalence continues to 
increase. This predominantly impacts African American men who make up 74% of persons 
living with HIV and 68% of death by AIDS. Despite the availability of antiretroviral drugs that 
allow for people living with HIV to lead healthy lives, Mississippians are still dying of AIDS at 
alarming rates. These trends are also seen in the Mississippi prison system as Mississippi is the 
fourth highest in the nation for prisoners who had HIV as percent of custody population. These 
issues are further complicated by Mississippi’s HIV-specific criminal law, Mississippi Code 
Ann. § 97-27-14. The statute relates to the crime of endangerment by bodily substance as applied 
to the prison population and includes urine, feces, and saliva, which are scientifically incorrect 
modes of HIV transmission. Based on national publications including the National HIV/AIDS 
Strategy for the United States: Updated to 2020 and the U.S. Department of Justice Civil Rights’ 
Best Practices Guide to reform HIV-Specific Criminal Laws to Align with Scientifically-
Supported Factors, HIV-specific criminal laws should be reformed to reflect accurate scientific 
information and to prevent further stigma to persons living with HIV. Despite all these factors, 
the Mississippi State Department of Health’s 2017-2021 Integrated HIV Prevention and Care 
Plan explicitly states that HIV-related criminal laws in Mississippi exist, but “before HIV 
decriminalization can happen, capacity building and awareness raising first occur and will be the 
focus of our efforts for the first year of this plan” and does not give a 5 year plan to holistically 
address HIV criminalization laws nor mention any plan related to the high prevalence of 
prisoners with HIV. Criminal laws serve as written guide for morality and justice. In having 
public health criminal statues based on unscientific and unrecommended information, 
Mississippi Code Ann. § 97-27-14 further perpetuates a culture of stigma for HIV/AIDS 
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furthering the Mississippi HIV/AIDS crisis. Mississippi Code Ann. § 97-27-14 must be 
methodologically reformed to reflect national standards.  
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Chapter 4: Method 
 I used the CDC’s Policy Analytical Framework to develop and analyze different HIV-
specific policy options for Mississippi based on suggestions from the National HIV/AIDS 
Strategy for the United States: Updated to 2020 and the U.S. Department of Justice Civil Rights’ 
Best Practices Guide to reform HIV-Specific Criminal Laws to Align with Scientifically-
Supported Factors. The CDC’s Policy and Analytical Framework consists of three domains: 
Problem Identification, Policy Analysis, and Strategy and Policy Development.  
 Domain 1 is Problem Identification; this consists of “identify[ing] the problem or issue” 
to have a specific issue/problem that would enable a “clear policy solution” (Centers for Disease 
Control and Prevention, 2013). Problem Identification consists of “synthesiz[ing] data on the 
characteristics of the problem or issue, including the burden (how many people it affects), 
frequency (how often it occurs), severity (how serious the problem is), and scope (range of 
outcomes it affects)” (Centers for Disease Control and Prevention, 2013). Ultimately, the issue or 
problem is clearly identified.  
 Domain 2 is Policy Analysis. Policy Analysis consists of three main parts: “identify and 
describe policy options,” “assess policy options,” and “prioritize policy options” (Centers for 
Disease Control and Prevention, 2013).  Identifying policy options consists of researching 
possible options related to the problem or issue. This includes conducting a literature review, 
looking at best practices, and performing an environmental scan to see what other 
states/jurisdictions have done. Describing policy options consists of elaborating on the options 
identified. This step includes answering framing questions “to describe the process and structure 
as well as the questions for each of the three interrelated criteria: health impact feasibility, and 
economic and budgetary impacts” (Table 1) (Centers for Disease Control and Prevention, 2013).   
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Table 1: Policy Analysis: Key Questions 
Framing Questions 
What is the policy lever – is it legislative, 
administrative, regulatory, other?   
What level of government institution will 
implement?   
How does the policy work/operate? (e.g. is it 
mandatory? Will enforcement be necessary? 
How is it funded? Who is responsible for 
administering the policy?)   
What are the objectives of the policy?   
What is the legal landscape surrounding the 
policy (e.g. court rulings, constitutionality)?   
What is the historical context (e.g. has the 
policy been debated previously)?   
What are the experiences of other 
jurisdictions?   
What is the value-added of the policy?   
What are the expected short, intermediate, 
and long-term outcomes?   
What might be the unintended positive and 
negative consequences of the policy?   
Public Health Impact: Potential for the policy to impact risk factors, quality 
of life, disparities, morbidity and mortality 
How does the policy address the problem or 
issue (e.g., increase access, protect from 
exposure)?   
What are the magnitude, reach, and 
distribution of benefit and burden (including 
impact on risk factor, quality of life, 
morbidity and mortality?   
What population(s) will benefit? How much? 
When?   
What population(s) will be negatively 
impacted? How much? When?   
Will the policy impact health 
disparities/health equity? How?   
Are there gaps in the data/evidence-base?   
Feasibility*: Likelihood that the policy can be successfully adopted and 
implemented 
Political 
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What are the current political forces 
including political history, environment, and 
debate?   
Who are the stakeholders, including 
supporters and opponents? What are their 
interests and values?   
What are the potential social, educational, 
and cultural perspectives associated with the 
policy option (e.g. lack of knowledge, fear of 
change, force of habit)?   
What are the potential impacts of the policy 
on other sectors and high priority issues (e.g. 
sustainability, economic impact)?   
Operational 
What are the resource, capacity, and 
technical needs developing, enacting, and 
implementing the policy?   
How much time is needed for the policy to 
be enacted, implemented, and enforced?   
How scalable, flexible, and transferable is 
the policy?   
 
*In assessing feasibility, identifying critical barriers that will prevent the policy from being 
adopted at the current time is important. For such policies, it may not be worthwhile to spend 
much time analyzing other factors (e.g. fiscal and economic impact). However, by identifying 
these critical barriers, you can be more readily able   
Economic and budgetary impacts: Comparison of the costs to enact, 
implement, and enforce the policy with the value of benefits 
Budget 
What are the costs and benefits associated 
with the policy, from a budgetary 
perspective?   
E.g. for public (federal, state, local) and 
private entities to enact, implement, and 
enforce the policy?   
Economic 
How do costs compare to benefits (e.g. cost-
savings costs averted, return on investments, 
cost-effectiveness, cost-benefit analysis, 
etc.)?   
How are costs and benefits distributed (e.g. 
for individuals, businesses, government)?   
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What is the timeline for costs and benefits?   
Where are the gaps in the data/evidence-
base?   
    
*** note where there are concerns about the quality or amount of data 
 
 After describing policy options, the next step is to assess policy options. Using the same 
criteria, policy options are independently scored based on a rating system seen in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Policy Analysis Table 
Criteria 
Public 
Health 
Impact Feasibility Economic and Budgetary Impact 
Scoring 
Definitio
ns 
Low: small 
reach, effect 
size and impact 
on disparate 
populations 
Low: No/small 
likelihood of 
being enacted 
Less favorable: High 
costs to implement 
Less Favorable: 
costs are high to 
benefits 
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Medium: small 
reach with 
large effect size 
or large reach 
with small 
effect size 
Medium: 
Moderate 
likelihood of 
being enacted 
Favorable: Moderate 
cost to implement 
Favorable: costs are 
moderate relative to 
benefits 
Large: large 
reach, effect 
size, and 
impact on 
disparate 
populations 
High: High 
likelihood of 
being enacted 
More Favorable: 
Low costs to 
implement 
More Favorable: 
costs are low relative 
to benefits 
      Budget Economic 
Policy 1 
Low/Medium/
High 
Low/Medium/
High 
Less 
Favorable/Favorable/
More Favorable  
Less 
Favorable/Favorable/
More Favorable  
Concerns about 
the amount or 
quality of data? 
Yes/No 
Concerns about 
the amount or 
quality of data? 
Yes/No 
Concerns about the 
amount or quality of 
data? Yes/No 
Concerns about the 
amount or quality of 
data? Yes/No 
Policy 2 
Low/Medium/
High 
Low/Medium/
High 
Less 
Favorable/Favorable/
More Favorable  
Less 
Favorable/Favorable/
More Favorable  
Concerns about 
the amount or 
quality of data? 
Yes/No 
Concerns about 
the amount or 
quality of data? 
Yes/No 
Concerns about the 
amount or quality of 
data? Yes/No 
Concerns about the 
amount or quality of 
data? Yes/No 
Policy 3 
Low/Medium/
High 
Low/Medium/
High 
Less Favorable 
Favorable/More 
Favorable  
Less 
Favorable/Favorable/
More Favorable  
Concerns about 
the amount or 
quality of data? 
Yes/No 
Concerns about 
the amount or 
quality of data? 
Yes/No 
Concerns about the 
amount or quality of 
data? Yes/No 
Concerns about the 
amount or quality of 
data? Yes/No 
 After policy options are assessed, policy options are evaluated against each other and 
policy options are prioritized based on the overall analysis.  
 Domain 3 is Strategy and Policy Development. This step is to “develop a strategy for 
furthering adoption of the policy solution” (Centers for Disease Control and Prevention, 2013).  
After a policy option is prioritized, a strategy is defined to get the policy enacted. To accomplish 
this, operational issues are clarified, information is shared, and, if needed, additional background 
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work is conducted. To clarify operational issues, “identify how the policy will operate and what 
steps are needed for policy implementation” (Centers for Disease Control and Prevention, 2013).  
To share information, share the results to stakeholders; to disseminate the information, develop 
products that “keep in mind the stakeholders’ information needs and preferred ways of receiving 
information” (Centers for Disease Control and Prevention, 2013).  This can be done via a 
summarization sheet, presentation, meetings, or other methods. Lastly, additional background 
work is conducted if needed. If the policy scored low in specific areas or there are concerns with 
the data, the policy can be reworked to more effectively address the problem or issue.  
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Chapter 5: Results 
 Using the CDC’s Policy Analytical Framework, first, data was synthesized to identify the 
overarching problem that § 97-27-14 is not scientifically accurate and negatively impacts the 
HIV crisis in Mississippi (Table 3).  
 
Table 3 
Next, possible policy options were identified. Based on the National HIV/AIDS Strategy 
for the United States: Updated to 2020, U.S. Department of Justice Civil Rights’ Best Practices 
Guide to reform HIV-Specific Criminal Laws to Align with Scientifically-Supported Factors, 
Georgia Code ANN. § 16-5-60, and the 2016 act proposed by Representative Hines to amend the 
crime of endangerment for bodily substances, three possible policies were identified.  
Burden
Approximately 9,236 
Mississippians living with HIV
Frequency
As of 2017, rate of 14.3 per 
100,000 population. 
Severity
Ranked 9 in the nation for 
diagnoses of HIV
Scope
Significantly impacts African 
American men who have sex with 
men, high rates of AIDS, current 
law scientifically incorrect and 
stigmatizing 
Identified 
Problem: 
§ 97-27-14 is not scientifically 
accurate and negatively impacts 
the HIV crisis in Mississippi 
Domain 1: Problem Identification
Step 1: Identify the Problem or Issue
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 Based off the 2016 amendment proposed by Representative Hines, the first policy option 
amends Mississippi Code § 97-27-14 to include only blood and seminal fluid. The Policy 1 
option states: 
“It shall be unlawful for any person to knowingly expose another person to human 
immunodeficiency virus (HIV).  Prior knowledge and willing consent to the exposure is 
a defense to a charge brought under this paragraph.  A violation of this subsection shall 
be a felony. 
(2)(a) A person commits the crime of endangerment by bodily substance if the person 
attempts to cause or knowingly causes a corrections employee, a visitor to a correctional 
facility or another prisoner or offender to come into contact with blood or seminal fluid. 
(b) As used in this subsection, the following definitions shall apply unless the context 
clearly requires otherwise: 
(i) “Corrections employee” means a person who is an employee or contracted employee 
of a subcontractor of a department or agency responsible for operating a jail, prison, 
correctional facility or a person who is assigned to work in a jail, prison or correctional 
facility. 
(ii) “Offender” means a person who is in the custody of the Department of Corrections. 
(iii) “Prisoner” means a person confined in a county or city jail. 
(c) A violation of this subsection is a misdemeanor unless the person violating this 
section knows that he is infected with human immunodeficiency virus (HIV, in which 
case it is a felony. 
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(3) Any person convicted of a felony violation of this section shall be imprisoned for not 
less than three (3) years nor more than ten (10) years and a fine of not more than Ten 
Thousand Dollars ($10,000.00), or both. 
(4) Any person guilty of a misdemeanor violation of this section shall be punished by 
imprisonment in the county jail for up to one (1) year and may be fined One Thousand 
Dollars ($1,000.00), or both.” 
(5) The provisions of this section shall be in addition to any other provisions of law for 
which the actions described in this section may be prosecuted. 
 The second policy option includes the clause “with the intent to transmit HIV” and also 
only includes blood and seminal fluids in the list of bodily substances. This policy is based off 
Georgia Code ANN. § 16-5-60, the National HIV/AIDS Strategy for the United States: Updated 
to 2020, and the U.S. Department of Justice Civil Rights’ Best Practices Guide to reform HIV-
Specific Criminal Laws to Align with Scientifically-Supported Factors. The Policy 2 Option 
states: 
It shall be unlawful for any person to knowingly expose another person to human 
immunodeficiency virus (HIV) with the intent to transmit HIV.  Prior knowledge and 
willing consent to the exposure is a defense to a charge brought under this paragraph.  A 
violation of this subsection shall be a felony. 
(2)(a) A person commits the crime of endangerment by bodily substance if the person 
attempts to cause or knowingly causes a corrections employee, a visitor to a correctional 
facility or another prisoner or offender to come into contact with blood or seminal fluid. 
(b) As used in this subsection, the following definitions shall apply unless the context 
clearly requires otherwise: 
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(i) “Corrections employee” means a person who is an employee or contracted employee 
of a subcontractor of a department or agency responsible for operating a jail, prison, 
correctional facility or a person who is assigned to work in a jail, prison or correctional 
facility. 
(ii) “Offender” means a person who is in the custody of the Department of Corrections. 
(iii) “Prisoner” means a person confined in a county or city jail. 
(c) A violation of this subsection is a misdemeanor unless the person violating this 
section intends to transmit HIV.  
(3) Any person convicted of a felony violation of this section shall be imprisoned 
for not less than three (3) years nor more than ten (10) years and a fine of not more than 
Ten Thousand Dollars ($10,000.00), or both. 
(4) Any person guilty of a misdemeanor violation of this section shall be punished by 
imprisonment in the county jail for up to one (1) year and may be fined One Thousand 
Dollars ($1,000.00), or both. 
(5) The provisions of this section shall be in addition to any other provisions of law for 
which the actions described in this section may be prosecuted. 
 The third policy option is to repeal Mississippi Code § 97-27-14. This option is based off 
of recommendations by the National HIV/AIDS Strategy for the United States: Updated to 2020 
and the general best practice suggested by the U.S. Department of Justice Civil Rights’ Best 
Practices Guide to reform HIV-Specific Criminal Laws to Align with Scientifically-Supported 
Factors. The Policy 3 option states: 
 Repeal Mississippi Code § 97-27-14. 
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 Next the policies were described and analyzed based on Public Health Impact, 
Feasibility, and Economic and Budgetary Impacts using Table 1: Policy Analysis: Key 
Questions. Tables 4-6 showcase the results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Policy Analysis: Key Questions 
 
Policy 1 Option 
  
Framing Questions 
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What is the policy lever – is it legislative, 
administrative, regulatory, other? 
Legislative 
What level of government institution will 
implement? State 
How does the policy work/operate? (e.g. is it 
mandatory? Will enforcement be necessary? 
How is it funded? Who is responsible for 
administering the policy?) 
This is related to criminal justice, so this will be 
administered by the court system. Enforcement is 
necessary because it is a criminal law.  
What are the objectives of the policy? 
The objectives of this policy are to amend the 
existing law to be scientifically accurate and 
reduce stigma. 
What is the legal landscape surrounding the 
policy (e.g. court rulings, constitutionality)? 
Nationally: United States V. Moore, State: 2008 
Shala Singleton Howell 
What is the historical context (e.g. has the 
policy been debated previously)? 
The law has been debated previously. A similar 
amendment was proposed in 2016 and failed.  
What are the experiences of other jurisdictions? 
33 states, 67 HIV-Specific criminal laws, Center 
for Disease Control and Prevention and the 
Department of Justice encourage laws to be 
reassessed 
What is the value-added of the policy? Adds scientific accuracy to existing policy 
What are the expected short, intermediate, and 
long-term outcomes? 
Adds scientific accuracy when law is utilized; is 
only a temporary solution and will need to be 
amended again because the amendment still 
furthers stigma and is not the ideal public health 
solution 
What might be the unintended positive and 
negative consequences of the policy? 
Does not include clause for criminal intent, could 
further stigma with disparity in sentencing for 
misdemeanor versus felony 
Public Health Impact: Potential for the policy to impact risk factors, quality of 
life, disparities, morbidity and mortality 
How does the policy address the problem or 
issue (e.g., increase access, protect from 
exposure)? 
Makes the law scientifically accurate by including 
only bodily substances that can transmit HIV 
What are the magnitude, reach, and distribution 
of benefit and burden (including impact on risk 
factor, quality of life, morbidity and mortality? 
Impact HIV/AIDS Mississippians: approximately 
200 prisoners, over 400 diagnoses yearly in 
Mississippi, over 9,000 living with HIV in 
Mississippi 
What population(s) will benefit? How much? 
When? HIV/AIDS populations as the law is scientifically 
correct. This has immediate impact as the 
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amendment reduces misinformation thereby 
reducing some stigma. 
What population(s) will be negatively 
impacted? How much? When? 
HIV/AIDS populations as the law is still HIV-
specific and is thereby still stigmatizing. 
Will the policy impact health disparities/health 
equity? How? 
The policy impacts health disparities in that 
HIV/AIDS disproportionately impacts Black men 
who have sex with men. The policy promotes 
health equity by including scientifically correct 
information.  
Are there gaps in the data/evidence-base? No.  
Feasibility*: Likelihood that the policy can be successfully adopted and 
implemented 
Political 
What are the current political forces including 
political history, environment, and debate? 
International/national agencies encouraging re-
assessment of HIV criminalization laws. Similar 
amendment introduced in 2016 and failed. Original 
law used only once in 2008, but there may be other 
instances where the law has been used that are not 
as widely noted. 
Who are the stakeholders, including supporters 
and opponents? What are their interests and 
values? 
Mississippi Legislators (protecting Mississippians, 
getting re-elected, etc.), Mississippians living with 
HIV/AIDS, HIV/AIDS advocacy organizations 
(equitable laws, decreasing stigma) 
What are the potential social, educational, and 
cultural perspectives associated with the policy 
option (e.g. lack of knowledge, fear of change, 
force of habit)? 
Lack of knowledge, stigma, fear, heteronormality, 
abstinence-plus education 
What are the potential impacts of the policy on 
other sectors and high priority issues (e.g. 
sustainability, economic impact)? Limited impact 
Operational 
What are the resource, capacity, and technical 
needs developing, enacting, and implementing 
the policy? 
Advocacy to lawmakers, mobilization of 
HIV/AIDS advocates/community to educate 
lawmakers, education, education about law to 
prison systems 
How much time is needed for the policy to be 
enacted, implemented, and enforced? Minimum 6 months 
How scalable, flexible, and transferable is the 
policy? 
The policy has the potential to be scalable, flexible, 
and transferable in relation to Hepatitis B and 
Hepatitis C-specific criminalization policies.  
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*In assessing feasibility, identifying critical barriers that will prevent the policy from being adopted at 
the current time is important. For such policies, it may not be worthwhile to spend much time 
analyzing other factors (e.g. fiscal and economic impact). However, by identifying these critical 
barriers, you can be more readily able  
Economic and budgetary impacts: Comparison of the costs to enact, implement, 
and enforce the policy with the value of benefits 
Budget 
What are the costs and benefits associated with 
the policy, from a budgetary perspective? Low costs 
E.g. for public (federal, state, local) and private 
entities to enact, implement, and enforce the 
policy? No cost change from previous policy 
Economic 
How do costs compare to benefits (e.g. cost-
savings costs averted, return on investments, 
cost-effectiveness, cost-benefit analysis, etc.)? 
There is limited cost change from the previous 
policy, yet in amending the law to be scientifically 
accurate, the policy reduces stigma. Stigma is often 
a reason people do not get tested for HIV or do not 
access needed resources, and so, by alleviating 
stigma, persons living with HIV will access needed 
resources sooner preventing the spread of the virus 
and more costly health problems.  
How are costs and benefits distributed (e.g. for 
individuals, businesses, government)? 
Healthcare industry as less costly health services, 
those living with HIV/AIDS by accessing needed 
health resources sooner and with less stigma, 
prison system having less prisoners based on more 
correct laws 
What is the timeline for costs and benefits? 6 months in relation with enactment 
Where are the gaps in the data/evidence-base? No 
Table 4 entailing the Policy 1 Option 
Table 5: Policy Analysis: Key Questions 
Policy 2 Option  
Framing Questions 
What is the policy lever – is it legislative, 
administrative, regulatory, other? Legislative 
What level of government institution will 
implement? State 
How does the policy work/operate? (e.g. is it 
mandatory? Will enforcement be necessary? 
This is related to criminal justice, so this will be 
administered by the court system. Enforcement is 
necessary because it is a criminal law.  
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How is it funded? Who is responsible for 
administering the policy?) 
What are the objectives of the policy? 
The objectives of this policy are to amend the 
existing law to be scientifically accurate, to 
decrease stigma, and include a cause for criminal 
intent. 
What is the legal landscape surrounding the 
policy (e.g. court rulings, constitutionality)? 
Nationally: United States V. Moore, State: 2008 
Shala Singleton Howell 
What is the historical context (e.g. has the 
policy been debated previously)? 
The law has been debated previously. A much 
more simplified amendment was proposed in 2016 
and failed.  
What are the experiences of other jurisdictions? 
33 states, 67 HIV-Specific criminal laws, Center 
for Disease Control and Prevention and the 
Department of Justice encourage laws to be 
reassessed encouraging clauses for intent if not 
repeal. There are several laws similar to this in 
states such as Georgia. 
What is the value-added of the policy? 
Adds scientific accuracy to existing policy, adds 
criminal intent to a criminal law 
What are the expected short, intermediate, and 
long-term outcomes? 
Adds scientific accuracy when law is utilized; 
includes clause relating to criminal intent.  
What might be the unintended positive and 
negative consequences of the policy? 
Potentially further stigma because of the difference 
between felony and misdemeanor, possibly 
stigmatize HIV as a possible weapon. Potentially 
makes the law more feasible in appeal to 
lawmakers and adds protection to those living with 
HIV who do not have criminal intent and those 
who could be victim to criminal intent as 
exemplified in domestic violence.  
Public Health Impact: Potential for the policy to impact risk factors, quality of 
life, disparities, morbidity and mortality 
How does the policy address the problem or 
issue (e.g., increase access, protect from 
exposure)? 
Makes the law scientifically accurate, adds 
criminal intent to decrease stigma 
What are the magnitude, reach, and distribution 
of benefit and burden (including impact on risk 
factor, quality of life, morbidity and mortality? 
Impact HIV/AIDS Mississippians: approximately 
200 prisoners, over 400 diagnoses yearly in 
Mississippi, over 9,000 living with HIV in 
Mississippi 
What population(s) will benefit? How much? 
When? 
HIV/AIDS populations as the law is scientifically 
correct/includes criminal clause to decriminalize  
What population(s) will be negatively 
impacted? How much? When? 
HIV/AIDS populations as the law is still HIV-
specific and thereby still stigmatizing 
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Will the policy impact health disparities/health 
equity? How? 
The policy impacts health disparities in that 
HIV/AIDS disproportionately impacts Black men 
who have sex with men. The policy promotes 
health equity by including scientifically correct 
information and accounts for criminal intent, 
decriminalizing certain behaviors.  
Are there gaps in the data/evidence-base? No 
Feasibility*: Likelihood that the policy can be successfully adopted and 
implemented 
Political 
What are the current political forces including 
political history, environment, and debate? 
International/national agencies encouraging re-
assessment of laws. Similar amendment failed  in 
2016. Original law used only once in 2008, but 
there may be other instances where the law has 
been used that are not as widely noted. Amending 
HIV-specific criminalization laws to include 
criminal intent is suggested by the Department of 
Justice, and these policies are seen in other states.  
Who are the stakeholders, including supporters 
and opponents? What are their interests and 
values? 
Mississippi Legislators (protecting Mississippians, 
getting re-elected, etc.), Mississippians living with 
HIV/AIDS, HIV/AIDS advocacy organizations 
(equitable laws, decreasing stigma) 
What are the potential social, educational, and 
cultural perspectives associated with the policy 
option (e.g. lack of knowledge, fear of change, 
force of habit)? 
Lack of knowledge, stigma, fear, heteronormality, 
abstinence-plus education,  
What are the potential impacts of the policy on 
other sectors and high priority issues (e.g. 
sustainability, economic impact)? Limited impact 
Operational 
What are the resource, capacity, and technical 
needs developing, enacting, and implementing 
the policy? 
Advocacy to lawmakers, mobilization of 
HIV/AIDS advocates/community to educate 
lawmakers, education, education about law to 
prison systems 
How much time is needed for the policy to be 
enacted, implemented, and enforced? Minimum 6 months 
How scalable, flexible, and transferable is the 
policy? 
The policy has the potential to be scalable, flexible, 
and transferable in relation to Hepatitis B and 
Hepatitis C-specific criminalization policies.  
*In assessing feasibility, identifying critical barriers that will prevent the policy from being adopted at 
the current time is important. For such policies, it may not be worthwhile to spend much time 
analyzing other factors (e.g. fiscal and economic impact). However, by identifying these critical 
barriers, you can be more readily able  
Economic and budgetary impacts: Comparison of the costs to enact, implement, 
and enforce the policy with the value of benefits 
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Budget 
What are the costs and benefits associated with 
the policy, from a budgetary perspective? Low costs 
E.g. for public (federal, state, local) and private 
entities to enact, implement, and enforce the 
policy? No cost change from previous policy  
Economic 
How do costs compare to benefits (e.g. cost-
savings costs averted, return on investments, 
cost-effectiveness, cost-benefit analysis, etc.)? 
There is limited cost change from the previous 
policy, yet in amending the law to be scientifically 
accurate and including a clause for criminal intent, 
the policy reduces stigma. Stigma is often a reason 
people do not get tested for HIV or do not access 
needed resources, and so, by alleviating stigma, 
persons living with HIV will access needed 
resources sooner preventing the spread of the virus 
and more costly health problems.  
How are costs and benefits distributed (e.g. for 
individuals, businesses, government)? 
Healthcare industry as less costly health services, 
those living with HIV/AIDS by accessing needed 
health resources sooner and with less stigma, 
prison system having less prisoners based on more 
correct laws 
What is the timeline for costs and benefits? 6 months in relation with enactment 
Where are the gaps in the data/evidence-base? No 
Table 5 entailing Policy 2 option. 
Table 6: Policy Analysis: Key Questions 
Policy 3 Option 
  
Framing Questions 
What is the policy lever – is it legislative, 
administrative, regulatory, other? 
Legislative 
What level of government institution will 
implement? State 
How does the policy work/operate? (e.g. is it 
mandatory? Will enforcement be necessary? 
How is it funded? Who is responsible for 
administering the policy?) 
This is related to criminal justice, so this will be 
administered by the court system. Because this is a 
repeal of a criminal law, enforcement is no longer 
necessary.  
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What are the objectives of the policy? 
The objectives of this policy are to decrease stigma 
for HIV/AIDS populations as based on the Center 
for Disease Control and Prevention and the 
Department of Justice suggestions and best 
practices. 
What is the legal landscape surrounding the 
policy (e.g. court rulings, constitutionality)? 
Nationally: United States V. Moore, State: 2008 
Shala Singleton Howell 
What is the historical context (e.g. has the 
policy been debated previously)? 
The law has been debated previously. A less 
extreme was proposed in 2016 and failed.  
What are the experiences of other jurisdictions? 
33 states, 67 HIV-Specific criminal laws, Center 
for Disease Control and Prevention and the 
Department of Justice encourage laws to be 
reassessed 
What is the value-added of the policy? Decreases stigma associated with criminalizing 
HIV 
What are the expected short, intermediate, and 
long-term outcomes? 
Ultimately decrease stigma for those living with 
HIV 
What might be the unintended positive and 
negative consequences of the policy? Fear related to HIV, increased education of 
lawmakers an and other communities 
Public Health Impact: Potential for the policy to impact risk factors, quality of 
life, disparities, morbidity and mortality 
How does the policy address the problem or 
issue (e.g., increase access, protect from 
exposure)? Decriminalizes HIV thereby decreasing stigma 
related to HIB 
What are the magnitude, reach, and distribution 
of benefit and burden (including impact on risk 
factor, quality of life, morbidity and mortality? 
Impact HIV/AIDS Mississippians: approximately 
200 prisoners, over 400 diagnoses yearly in 
Mississippi, over 9,000 living with HIV in 
Mississippi 
What population(s) will benefit? How much? 
When? HIV/AIDS populations  
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What population(s) will be negatively 
impacted? How much? When? 
Conversation surrounding the policy could 
negatively impact HIV/AIDS populations initially. 
General population could be negatively impacted 
regarding potential for domestic violence and 
criminal intent, yet these are mild concerns that 
have the potential to be addressed in other laws.  
Will the policy impact health disparities/health 
equity? How? 
The policy impacts health disparities in that 
HIV/AIDS disproportionately impacts Black 
MSM. The policy promotes health equity by 
decriminalizing HIV.  
Are there gaps in the data/evidence-base? 
No  
Feasibility*: Likelihood that the policy can be successfully adopted and 
implemented 
Political 
What are the current political forces including 
political history, environment, and debate? 
International/national agencies encouraging re-
assessment of HIV criminalization laws. Similar 
amendment introduced in 2016 and failed. Original 
law used only once in 2008, but there may be other 
instances where the law has been used that are not 
as widely noted. Repealing HIV-specific criminal 
laws is the best practice as suggested by the 
Department of Justice.  
Who are the stakeholders, including supporters 
and opponents? What are their interests and 
values? 
Mississippi Legislators (protecting Mississippians, 
getting re-elected, etc.), Mississippians living with 
HIV/AIDS, HIV/AIDS advocacy organizations 
(equitable laws, decreasing stigma) 
What are the potential social, educational, and 
cultural perspectives associated with the policy 
option (e.g. lack of knowledge, fear of change, 
force of habit)? 
Lack of knowledge, stigma, fear, heteronormality, 
abstinence-plus education, want to protect 
Mississippi citizens 
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What are the potential impacts of the policy on 
other sectors and high priority issues (e.g. 
sustainability, economic impact)? Limited impact 
Operational 
What are the resource, capacity, and technical 
needs developing, enacting, and implementing 
the policy? 
Advocacy to lawmakers, mobilization of 
HIV/AIDS advocates/community to educate 
lawmakers, education, education about law to 
prison systems 
How much time is needed for the policy to be 
enacted, implemented, and enforced? Minimum 6 months 
How scalable, flexible, and transferable is the 
policy? 
The policy has the potential to be scalable, flexible, 
and transferable in relation to Hepatitis B and 
Hepatitis C-specific criminalization policies.  
*In assessing feasibility, identifying critical barriers that will prevent the policy from being adopted at 
the current time is important. For such policies, it may not be worthwhile to spend much time 
analyzing other factors (e.g. fiscal and economic impact). However, by identifying these critical 
barriers, you can be more readily able  
Economic and budgetary impacts: Comparison of the costs to enact, implement, 
and enforce the policy with the value of benefits 
Budget 
What are the costs and benefits associated with 
the policy, from a budgetary perspective? Low costs 
E.g. for public (federal, state, local) and private 
entities to enact, implement, and enforce the 
policy? No cost change from previous policy  
Economic 
How do costs compare to benefits (e.g. cost-
savings costs averted, return on investments, 
cost-effectiveness, cost-benefit analysis, etc.)? 
There is limited cost change from the previous 
policy, yet in decriminalizing HIV, the policy 
greatly reduces stigma. Stigma is often a reason 
people do not get tested for HIV or do not access 
needed resources, and so, by alleviating stigma, 
persons living with HIV will access needed 
resources sooner preventing the spread of the virus 
and more costly health problems.  
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How are costs and benefits distributed (e.g. for 
individuals, businesses, government)? 
Healthcare industry as less costly health services, 
those living with HIV/AIDS by accessing needed 
health resources sooner and with less stigma, 
prison system having less prisoners based on more 
correct laws 
What is the timeline for costs and benefits? 6 months in relation with enactment 
Where are the gaps in the data/evidence-base? No 
Table 6 entailing Policy 3 option. 
After describing policy options, the policy options were scored independently based on 
Public Health Impact, Feasibility and Economic and Budgetary Impact. Table 6 shows the 
scoring results.  
 
 
Table 7: Policy Analysis Table 
Criteria Public Health Impact Feasibility 
Economic and Budgetary 
Impact 
Scoring 
Definitions Low: small reach, effect 
size and impact on 
disparate populations 
Low: No/small 
likelihood of being 
enacted 
Less favorable: 
High costs to 
implement 
Less Favorable: 
costs are high to 
benefits 
Medium: small reach 
with large effect size or 
large reach with small 
effect size 
Medium: 
Moderate 
likelihood of being 
enacted 
Favorable: 
Moderate cost to 
implement 
Favorable: costs 
are moderate 
relative to 
benefits 
Large: large reach, 
effect size, and impact 
on disparate populations 
High: High 
likelihood of being 
enacted 
More 
Favorable: Low 
costs to 
implement 
More Favorable: 
costs are low 
relative to 
benefits 
      Budget Economic 
Policy 1 Low  Medium  More Favorable  More Favorable  
Concerns about the 
amount or quality of 
data? No 
Concerns about the 
amount or quality 
of data? No 
Concerns about 
the amount or 
quality of data? 
No 
Concerns about 
the amount or 
quality of data? 
No 
Policy 2 Medium  Medium  More Favorable  More Favorable  
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Concerns about the 
amount or quality of 
data? No 
Concerns about the 
amount or quality 
of data? No 
Concerns about 
the amount or 
quality of data? 
No 
Concerns about 
the amount or 
quality of data? 
No 
Policy 3 High Low  More Favorable  More Favorable  
Concerns about the 
amount or quality of 
data? No 
Concerns about the 
amount or quality 
of data? No 
Concerns about 
the amount or 
quality of data? 
No 
Concerns about 
the amount or 
quality of data? 
No 
Table 7 
Based on the policy analysis, Policy 2 is prioritized, but concerns are noted for the overall 
public health impact.  
Finally, during Strategy and Policy Development, a strategy is created to account for the 
public health impact. 
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 Table 8 
 As the strategy and policy development in Table 7 show, the prioritized policy is Policy 
option 2 to amend Mississippi’s HIV-specific criminalization law to be scientifically correct and 
include a criminalization clause. Because this is not the ideal public health solution, the strategy 
is modified to be more incremental in building the foundation for Mississippi’s HIV-specific 
criminalization law to be repealed while advocating for the current best policy option, Policy 
Option 2.  
Enactment of Policy 2 while building the foundation to decriminalize HIV is done by first 
discussing the current policy option and strategy with stakeholders including AIDS Services 
Clarifying Operational 
Issues
Discuss Policy 2 with relevant 
stakeholders, educate Mississippi 
state legislators about implications of 
current policy, get a Mississippi state 
legislator to sponsor the bill, 
continue to advocate for bill
Sharing Information
Share with relevant stakeholders 
including AIDS Services Coalition, 
My Brother's Keeper, Inc, Center for 
Mississippi Health Policy, 
Mississippi legislature public health 
committees, Mississippians living 
with HIV 
Conducting Additional 
Background Work
Based on concerns with Policy 2's 
public health impact, modify the 
policy strategy to be more 
incremental in advocating for Policy 
2 while continuing to work for 
Policy 3
Domain 3: Strategy and Policy Development
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Coalition, My Brother’s Keeper, Inc, Center for Mississippi Health Policy, Public Health 
Committees in the Mississippi Legislature, Mississippians living with HIV, and other relevant 
stakeholders. Once the policy option and strategy are discussed, see if changes should be made to 
the policy option and/or strategy. After discussing the policy and strategy with stakeholders, 
begin educating Mississippi state legislators about the implications of the current policy while 
also addressing the HIV/AIDS crisis in Mississippi and implications of HIV-criminalization as a 
whole. After educating legislators, get a Mississippi state legislator to sponsor the bill. Finally, 
mobilize stakeholders to continue to advocate for the bill throughout the Mississippi House of 
Representatives and Senate.  
 
 
  
  42 
Chapter 6: Findings and Discussion 
After identifying the overarching problem being that Mississippi Code § 97-27-14 is not 
scientifically accurate and negatively impacts the HIV crisis in Mississippi, three policy options 
were identified. Policy 1 amends the original policy to only blood and seminal fluid, Policy 2 
amends the original policy to only include blood and seminal fluid and includes criminal intent, 
and Policy 3 is to repeal Mississippi Code § 97-27-14.  
When describing the policy options, there were varied concerns with each policy. Policy 
1 amends the original law to be scientifically correct, yet the law is still stigmatizing as it does 
not include a clause for criminal intent, includes the disparity in sentencing for a misdemeanor 
versus felony, singles out persons living with HIIV, and further stigmatizes those living with 
HIV. Policy 2 amends the original law by including criminal intent and scientifically correct 
information, yet this policy option still stigmatizes as the policy singles out persons living with 
HIV, includes the disparity in sentencing for a misdemeanor versus felony, and still further 
stigmatizes person living with HIV in the idea of HIV as a weapon. Policy 3 is the repeal of 
Mississippi Code § 97-27-14; while this policy option is the least stigmatizing option for persons 
living with HIV, the major concern is regarding feasibility. While all of the policy options regard 
extensive education for policy makers, repealing Mississippi Code § 97-27-14 requires the most 
extensive educational measures and raises concerns with the concept of  protecting 
Mississippians.  
After describing policy options, Policy 1, 2, and 3 were assessed. Policy 1 scored low for 
Public Health Impact, medium for Feasibility, and more favorable for both Economic and 
Budgetary Impact. While Policy 1 amends the law to be scientifically accurate, the law does not 
account for criminal intent, which makes it have a limited public health impact. Also, this law is 
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still stigmatizing because this is still a HIV-specific criminal law and the discrepancy still exists 
between misdemeanor and felony. Despite the very similar amendment to the 2016 Mississippi 
Legislature failing, this policy has a moderate likelihood of being enacted if proper advocacy 
measures are put in place including stakeholder mobilization and education of lawmakers. This 
policy change would ultimately cost the same as Mississippi Code § 97-27-14 while possibly 
reducing healthcare costs through the alleviation of stigma ultimately making this policy more 
favorable for Economic and Budgetary Impact.  
Policy 2 scored medium for Public Health Impact, medium for Feasibility, and more 
favorable for both Economic and Budgetary Impact. Policy 2 amends the law to be scientifically 
accurate and includes the clause of criminal intent to be a felony. Yet, this policy is still 
classified as a HIV-specific law furthering stigma, and there is still the clause for a misdemeanor, 
which does not account for criminal intent. Yet, HIV-specific policies are created with the 
intention of protecting citizens, despite limited evidence that it works, and so, this policy’s 
criminal intent clause benefits both parties as it accounts for those affected by criminal intent and 
persons living with HIV who did not have criminal intent. Overall, this policy has a medium 
public health impact because of its large reach and small effect size. Because this policy appeals 
to various stakeholders in accounting for criminal intent, this policy has a moderate likelihood of 
being enacted if proper advocacy measures are put in place including the mobilization of 
stakeholders and continued educational efforts of lawmakers. Policy 2 would ultimately cost the 
same as Mississippi Code § 97-27-14 while possibly reducing healthcare costs through the 
alleviation of stigma and possibly reduce criminalization rates ultimately making this policy 
more favorable for Economic and Budgetary Impact. 
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Policy 3 scored large for Public Health Impact, low for Feasibility, and more favorable 
for both Economic and Budgetary Impact. Policy 3 is the repeal of Mississippi Code § 97-27-14. 
This policy has the greatest public health impact in that this repeal decriminalizes HIV greatly 
reducing stigma for people living with HIV. While this policy has the most significant public 
health impact, based on current attitudes, understanding, and pre-existing stigma of HIV by 
Mississippi legislators and other Mississippians, this policy has a significantly lower chance of 
being implemented. Policy 3 would ultimately cost the same as Mississippi Code § 97-27-14 
while possibly reducing healthcare costs through the alleviation of stigma and ultimately 
reducing criminalization rates making this policy more favorable for Economic and Budgetary 
Impact. 
 Once policy options were assessed and scored, Policy 2 was prioritized based on the 
moderate Public Health Impact and Feasibility, yet concerns were noted that Policy 2 is not the 
ideal public health solution. To account for the fact that the ideal public health solution is to 
repeal the HIV-specific criminal law, the strategy was modified to be more incremental in 
advocating for the immediate policy solution to be Policy 2 while building the foundation and 
continuing to work for Policy 3. This is done by first discussing Policy 2 and the strategy with 
relevant stakeholders to possibly modify the policy and strategy and mobilize stakeholders. After 
discussing Policy 2 with stakeholders, educate Mississippi legislators about the Mississippi 
HIV/AIDS crisis, implications of Mississippi Code § 97-27-14, and overall stigmatizing effects 
of HIV-specific criminalization while advocating for Policy 2. In this education and advocacy 
phase, the immediate policy solution is advocated for while the educational foundations and 
decrease of stigma are beginning for the foundation for the repeal of Mississippi Code § 97-27-
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14. After this step, get a Mississippi legislator to sponsor the bill and continue to advocate for the 
bill as it goes through Mississippi State House of Representatives and Senate.  
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Chapter 7: Conclusion and Directions for Future Research 
Ultimately, Mississippi § 97-27-14 must be reformed to reflect national standards and to 
decrease misinformation and stigma for those living with HIV in Mississippi. The current best 
policy option based on Public Health Impact and Feasibility is to amend the code to be 
scientifically accurate and include a clause for criminal intent. Because this is not the ideal public 
health solution, the strategy must include building the foundation to continually work for 
ultimately repealing Mississippi’s HIV-specific criminalization law while advocating for the 
current best policy solution. Amidst the HIV/AIDS crisis in Mississippi, it is critical that 
Mississippi Code § 97-27-14 is reformed to decrease stigma that continues to hurt Mississippians 
living with HIV.  
The findings of this policy analysis suggest directions for future research. Mississippi is 
currently ranked second in the nation for percentages of prisoners living with HIV. This is an 
alarming number, and yet, no literature exists about the high percentage, and it is not mentioned 
in the Mississippi State Department of Health 2017-2021 Integrated HIV Prevention and Care 
Plan. It is critical that the high percentage is further researched, so that the health needs of this 
population are met. Secondly, Hepatitis B and Hepatitis C are included in Mississippi Code § 97-
27-14, yet for the purpose of this study, Hepatitis B and C were not included.  Further research 
and analysis should be done for Hepatitis B and C-specific criminalization laws to determine if 
the suggested policy option determined for Mississippi’s HIV-criminalization laws would be 
applicable. Lastly, there are numerous policies by the Mississippi Department of Health 
regarding HIV treatment and prevention efforts. It is important for these laws to be re-examined 
and reformed to meet national standards, improve access for those living with HIV, and ensure 
these policies meet the health needs of vulnerable Mississippians.  
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